NOVT Stock Overview
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$153.50 |
| 52 Week High | US$187.12 |
| 52 Week Low | US$146.86 |
| Beta | 1.27 |
| 1 Month Change | -9.59% |
| 3 Month Change | -12.96% |
| 1 Year Change | -9.02% |
| 3 Year Change | -11.33% |
| 5 Year Change | 70.88% |
| Change since IPO | 863.13% |
Recent News & Updates
Recent updates
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price
Dec 21
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital
Oct 15What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S
Sep 12Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold
Sep 02Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?
Aug 24Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price
Aug 02Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively
Jun 22Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
May 30Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)
May 08Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger
Feb 24Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?
Feb 05Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely
Dec 29Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance
Aug 09Shareholder Returns
| NOVT | US Electronic | US Market | |
|---|---|---|---|
| 7D | -7.6% | -3.1% | -2.4% |
| 1Y | -9.0% | 17.6% | 23.3% |
Return vs Industry: NOVT underperformed the US Electronic industry which returned 17.6% over the past year.
Return vs Market: NOVT underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| NOVT volatility | |
|---|---|
| NOVT Average Weekly Movement | 5.1% |
| Electronic Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NOVT has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NOVT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| NOVT fundamental statistics | |
|---|---|
| Market cap | US$5.51b |
| Earnings (TTM) | US$60.13m |
| Revenue (TTM) | US$922.75m |
91.7x
P/E Ratio6.0x
P/S RatioIs NOVT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOVT income statement (TTM) | |
|---|---|
| Revenue | US$922.75m |
| Cost of Revenue | US$517.88m |
| Gross Profit | US$404.88m |
| Other Expenses | US$344.74m |
| Earnings | US$60.13m |
Last Reported Earnings
Sep 27, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.67 |
| Gross Margin | 43.88% |
| Net Profit Margin | 6.52% |
| Debt/Equity Ratio | 61.6% |
How did NOVT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:07 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Novanta Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Mason | Baird |
| Ishan Majumdar | Baptista Research |
| Andrew Buscaglia | Berenberg |